| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.201309-1573ED |
| P698 | PubMed publication ID | 24236585 |
| P50 | author | Gary B Huffnagle | Q89273784 |
| Fernando J Martinez | Q89536935 | ||
| P2093 | author name string | Robert P Dickson | |
| Yvonne J Huang | |||
| P2860 | cites work | The impact of COPD on lung health worldwide: epidemiology and incidence | Q47685973 |
| Exacerbations of chronic obstructive pulmonary disease. | Q53175930 | ||
| Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. | Q54617796 | ||
| Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 | ||
| Analysis of the lung microbiome in the "healthy" smoker and in COPD | Q21091065 | ||
| Animal models of chronic obstructive pulmonary disease | Q28385105 | ||
| Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. | Q31134621 | ||
| The role of the bacterial microbiome in lung disease | Q33554623 | ||
| Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease | Q34390389 | ||
| The lung microbiome in moderate and severe chronic obstructive pulmonary disease | Q34448176 | ||
| Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation | Q34840845 | ||
| A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. | Q35049328 | ||
| Azithromycin for prevention of exacerbations of COPD. | Q35564000 | ||
| The lung tissue microbiome in chronic obstructive pulmonary disease | Q35987112 | ||
| Infection in the pathogenesis and course of chronic obstructive pulmonary disease | Q37336494 | ||
| Chronic obstructive pulmonary disease phenotypes: the future of COPD. | Q39867138 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| microbiome | Q1330402 | ||
| P304 | page(s) | 1185-1186 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches | |
| P478 | volume | 188 |
| Q26766294 | Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs |
| Q35981753 | Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer. |
| Q28655573 | Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013 |
| Q57125607 | Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases |
| Q64083780 | Influence of Thiazolidine-2,4-Dione Derivatives with Azolidine or Thiosemicarbazone Moieties on spp. Planktonic or Biofilm-Forming Cells |
| Q57494125 | Lung tissue microbial profile in lung cancer is distinct from emphysema |
| Q36031725 | Piglet nasal microbiota at weaning may influence the development of Glässer's disease during the rearing period |
| Q38208185 | The path to personalised medicine in COPD. |
| Q34440594 | The potential role of lung microbiota in lung cancer attributed to household coal burning exposures |
| Q92815481 | The respiratory tract microbiome and its relationship to lung cancer and environmental exposures found in rural china |
| Q35199001 | Update in sepsis and pulmonary infections 2013. |
Search more.